Abstract
Background
Bariatric surgery has been established as the best option of treatment for morbid obesity. Recently, laparoscopic sleeve gastrectomy (SG) has become very popular because of good postoperative weight loss and low morbidity. The aim of this study was to report our single-center experience with SG regarding feasibility, morbidity, and outcome.
Methods
From January 2006 to December 2011, 93 patients (68 female) with a median age of 46 years underwent laparoscopic SG at our department. Thirteen patients had a history of gastric banding with insufficient weight loss or band-related complications. Clinical outcome and laboratory findings were analyzed.
Results
The mean preoperative and postoperative body mass index (BMI) was 44.1 ± 6.9 and 33.4 ± 6.8 kg/m2, respectively (p < 0.001). The mean excessive body weight loss after a median follow-up of 11.9 months was 55.7 % ± 24.9 %. Three bleedings, two staple line leakages, and a deep wound infection required conversion to laparotomy (n = 1), reoperation (n = 4), or endoscopic stent implantation (n = 2). Resolution of diabetes and dyslipidemia was seen in 85 and 50 % of patients, respectively. Blood test results of HbA1c, cholesterols, triglycerides, and leptin showed significant postoperative improvement.
Conclusions
Laparoscopic SG represents a feasible bariatric procedure with good short-term weight loss, low morbidity rate, and efficient resolution of diabetes and dyslipidemia, especially in patients with lower BMI. The significant decrease of leptin necessitates further studies to understand the ambiguous role of leptin in bariatric surgery.
Similar content being viewed by others
References
Frezza EE, Wachtel MS. The economic impact of morbid obesity. Surg Endosc. 2009;23(4):677–9.
Glatt D, Sorenson T. Metabolic and bariatric surgery for obesity: a review. S D Med Spec . 2011;57–62.
Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8(3):267–82.
Regan JP, Inabnet WB, et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13(6):861–4.
Deitel M, Crosby RD, et al. The First International Consensus Summit for Sleeve Gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg. 2008;18(5):487–96.
Brethauer SA, Hammel JP, et al. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis. 2009;5(4):469–75.
Gagner M, Deitel M, et al. The Second International Consensus Summit for Sleeve Gastrectomy, March 19–21, 2009. Surg Obes Relat Dis. 2009;5(4):476–85.
Lakdawala MA, Bhasker A, et al. Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study. Obes Surg. 2010;20(1):1–6.
Omana JJ, Nguyen SQ, et al. Comparison of comorbidity resolution and improvement between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. Surg Endosc. 2010;24(10):2513–7.
Gumbs AA, Gagner M, et al. Sleeve gastrectomy for morbid obesity. Obes Surg. 2007;17(7):962–9.
Akkary E, Duffy A, et al. Deciphering the sleeve: technique, indications, efficacy, and safety of sleeve gastrectomy. Obes Surg. 2008;18(10):1323–9.
Sammour T, Hill AG, et al. Laparoscopic sleeve gastrectomy as a single-stage bariatric procedure. Obes Surg. 2010;20(3):271–5.
Nehoda H, Weiss H, et al. Results and complications after adjustable gastric banding in a series of 250 patients. Am J Surg. 2001;181(1):12–5.
Mittermair RP, Obermüller S, et al. Results and complications after Swedish adjustable gastric banding—10 years experience. Obes Surg. 2009;19(12):1636–41.
Lanthaler M, Mittermair R, et al. Laparoscopic gastric re-banding versus laparoscopic gastric bypass as a rescue operation for patients with pouch dilatation. Obes Surg. 2006;16(4):484–7.
Perathoner A, Weiss H, et al. Is a pouch compulsory in Roux-en-Y gastric bypass after failed adjustable gastric banding? Obes Surg. 2008;18(12):1544–50.
Almogy G, Crookes PF, et al. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg. 2004;14(4):492–7.
Mognol P, Chosidow D, et al. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg. 2005;15(7):1030–3.
Himpens J, Dapri G, et al. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16(11):1450–6.
Abbatini F, Rizzello M, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24(5):1005–10.
Lanthaler M, Aigner F, et al. Long-term results and complications following adjustable gastric banding. Obes Surg. 2010;20:1078–85.
Ramalingam G, Anton CK. Our 1-year experience in laparoscopic sleeve gastrectomy. Obes Surg. 2011;21(12):1828–33.
Prasad P, Tantia O, et al. An analysis of 1–3-year follow-up results of laparoscopic sleeve gastrectomy: an Indian perspective. Obes Surg. 2012;22(3):507–14.
Langer FB, Reza Hoda MA, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15(7):1024–9.
Kotidis EV, Koliakos GG, et al. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment—a prospective study. Obes Surg. 2006;16(11):1425–32.
Frezza EE, Chiriva-Internati M, et al. Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today. 2008;38(6):481–3.
Holst JJ. The physiology of glucagon like peptide 1. Physiol Rev. 2007;87:1409–39.
Gutzwiller JP, Goke B, et al. Glucagon like peptide 1: a potent regulator of food intake in humans. Gut. 2008;44:81–6.
Ramon JM, Salvans S, et al. Effect of Roux en Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomized trial. J Gastrointest Surg. 2012;16:1116–22.
Michalakis K, Le Roux C. Gut hormones and leptin: impact on energy control and changes after bariatric surgery—what the future holds. Obes Surg. 2012;22:1648–57.
Jacobs M, Bisland W, et al. Laparoscopic sleeve gastrectomy: a retrospective review of 1 and 2 years results. Surg Endosc. 2010;24(4):781–5.
Menenakos E, Stamou K, et al. Laparoscopic sleeve gastrectomy performed with intent to treat morbid obesity: a prospective single-center study of 261 patients with a median follow up of 1 year. Obes Surg. 2010;20(3):276–82.
Sanchez-Santos R, Masdevall C, et al. Short and midterm outcomes of sleeve gastrectomy for morbid obesity: the experience of the Spanish National Registry. Obes Surg. 2009;19(9):1203–10.
Bellanger D, Greenway F. Laparoscopic sleeve gastrectomy, 529 cases without a leak: short term results and technical considerations. Obes Surg. 2011;21(2):146–50.
Fischer L, Hildebrandt C, et al. Excessive weight loss after sleeve gastrectomy: a systematic review. Obes Surg. 2012;22:721–31.
Chowbey PK, Dhawan K, et al. Laparoscopic sleeve gastrectomy: an Indian experience-surgical technique and early results. Obes Surg. 2010;20(10):1340–7.
Lee WJ, Chen CY, et al. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis. 2011;7(6):683–90.
Woelnerhanssen B, Peterli R, et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux en Y gastric bypass and laparoscopic sleeve gastrectomy—a prospective randomized trial. Surg Obes Relat Dis. 2011;7(5):561–8.
Marantos G, Daskalakis M, et al. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery. World J Surg. 2011;35(9):2022–30.
Stefater M, Perez-Tilve D, et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology. 2010;138(7):2426–36.
Rodriguez A, Becerril S, et al. Short term effects of sleeve gastrectomy and caloric restriction on blood pressure in diet induced obese rats. Obes Surg. 2012;22:1481–90.
Gautron L, Elmquist JK, et al. Sixteen years and counting: an update on leptin in energy balance. J Clin Invest. 2011;121:2087–93.
Lopez P, Nicholson S, et al. Development of a sleeve gastrectomy weight loss model in obese Zucker rats. J Surg Res. 2009;157:243–50.
Lacy A, Ibarzabal A, et al. Revisional surgery after sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech. 2010;20(5):351–6.
Iannelli A, Schneck AS, et al. Laparoscopic sleeve gastrectomy as revisional procedure for failed gastric banding and vertical banded gastroplasty. Obes Surg. 2009;19(9):1216–20.
Foletto M, Prevedello L, et al. Sleeve gastrectomy as revisional procedure for failed gastric banding or gastroplasty. Surg Obes Relat Dis. 2010;6(2):146–51.
Baker RS, Foote J, et al. The science of stapling and leaks. Obes Surg. 2004;14(10):1290–8.
Consten EC, Gagner M, et al. Decreased bleeding after laparoscopic sleeve gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed absorbable polymer membrane. Obes Surg. 2004;14(10):1360–6.
Himpens J, Dobbeleir J, et al. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252(2):319–24.
D’Hondt M, Vanneste S, et al. Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc. 2011;25(8):2498–504.
Conflict of Interest
All the authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perathoner, A., Weißenbacher, A., Sucher, R. et al. Significant Weight Loss and Rapid Resolution of Diabetes and Dyslipidemia During Short-Term Follow-Up After Laparoscopic Sleeve Gastrectomy. OBES SURG 23, 1966–1972 (2013). https://doi.org/10.1007/s11695-013-1038-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-013-1038-4